Low baseline pulmonary levels of cytotoxic lymphocytes as a predisposing risk factor for severe COVID-19

por Duijf, Pascal H.G.
Publicado 2020

Low Baseline Pulmonary Levels of Cytotoxic Lymphocytes as a Predisposing Risk Factor for Severe COVID-19

por Duijf, Pascal H. G.
Publicado 2020

Complexities of pharmacogenomic interactions in cancer

por Khanna, Kum Kum, Duijf, Pascal H.G.
Publicado 2020

In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion

por Thangavelu, Pulari U., Krenács, Tibor, Dray, Eloise, Duijf, Pascal H. G.
Publicado 2016

Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers

por Janysek, Dawn C., Kim, Jennifer, Duijf, Pascal H.G., Dray, Eloïse
Publicado 2021

EYA4 drives breast cancer progression and metastasis through its novel role in replication stress avoidance

por de la Peña Avalos, Bárbara, Tropée, Romain, Duijf, Pascal H. G., Dray, Eloïse
Publicado 2023

EYA4 promotes breast cancer progression and metastasis through its role in replication stress avoidance

por de la Peña Avalos, Bárbara, Tropée, Romain, Duijf, Pascal H. G., Dray, Eloïse
Publicado 2023

Contradictory mRNA and protein misexpression of EEF1A1 in ductal breast carcinoma due to cell cycle regulation and cellular stress

por Lin, Cheng-Yu, Beattie, Alexandra, Baradaran, Behzad, Dray, Eloise, Duijf, Pascal H. G.
Publicado 2018

Translocation Breakpoints Preferentially Occur in Euchromatin and Acrocentric Chromosomes

por Lin, Cheng-Yu, Shukla, Ankit, Grady, John P., Fink, J. Lynn, Dray, Eloise, Duijf, Pascal H.G.
Publicado 2018

Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma

por Huang, Xiaomin, Duijf, Pascal H. G., Sriram, Sharath, Perera, Ganganath, Vasani, Sarju, Kenny, Lizbeth, Leo, Paul, Punyadeera, Chamindie
Publicado 2023

Overexpression of the E2F target gene CENPI promotes chromosome instability and predicts poor prognosis in estrogen receptor-positive breast cancer

por Thangavelu, Pulari U., Lin, Cheng-Yu, Vaidyanathan, Srividya, Nguyen, Thu H.M., Dray, Eloise, Duijf, Pascal H.G.
Publicado 2017

HMGA2 as a Critical Regulator in Cancer Development

por Mansoori, Behzad, Mohammadi, Ali, Ditzel, Henrik J., Duijf, Pascal H. G., Khaze, Vahid, Gjerstorff, Morten F., Baradaran, Behzad
Publicado 2021

Dysregulated G2 phase checkpoint recovery pathway reduces DNA repair efficiency and increases chromosomal instability in a wide range of tumours

por Fernando, Madushan, Duijf, Pascal H. G., Proctor, Martina, Stevenson, Alexander J., Ehmann, Anna, Vora, Shivam, Skalamera, Dubravka, Adams, Mark, Gabrielli, Brian
Publicado 2021

miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis

por Mansoori, Behzad, Silvestris, Nicola, Mohammadi, Ali, Khaze, Vahid, Baghbani, Elham, Mokhtarzadeh, Ahad, Shanehbandi, Dariush, Derakhshani, Afshin, Duijf, Pascal H. G., Baradaran, Behzad
Publicado 2021

COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic Target

por Suraweera, Amila, Duijf, Pascal H. G., Jekimovs, Christian, Schrobback, Karsten, Liu, Cheng, Adams, Mark N., O’Byrne, Kenneth J., Richard, Derek J.
Publicado 2021

STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients

por Safarzadeh, Elham, Mohammadi, Ali, Mansoori, Behzad, Duijf, Pascal H. G., Hashemzadeh, Shahryar, Khaze, Vahid, Kazemi, Tohid, Derakhshani, Afshin, Silvestris, Nicola, Baradaran, Behzad
Publicado 2021

Identification of Common and Distinct Pathways in Inflammatory Bowel Disease and Colorectal Cancer: A Hypothesis Based on Weighted Gene Co-Expression Network Analysis

por Derakhshani, Afshin, Javadrashid, Darya, Hemmat, Nima, Dufour, Antoine, Solimando, Antonio Giovanni, Abdoli Shadbad, Mahdi, Duijf, Pascal H. G., Brunetti, Oronzo, Silvestris, Nicola, Baradaran, Behzad
Publicado 2022

SASH1 is a prognostic indicator and potential therapeutic target in non-small cell lung cancer

por Burgess, Joshua T., Bolderson, Emma, Adams, Mark N., Duijf, Pascal H. G., Zhang, Shu-Dong, Gray, Steven G., Wright, Gavin, Richard, Derek J., O’Byrne, Kenneth J.
Publicado 2020

Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer

por Suraweera, Amila, Duff, Alex, Adams, Mark N., Jekimovs, Christian, Duijf, Pascal H. G., Liu, Cheng, McTaggart, Matthew, Beard, Sam, O’Byrne, Kenneth J., Richard, Derek J.
Publicado 2020

Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer

por Suraweera, Amila, Duff, Alex, Adams, Mark N., Jekimovs, Christian, Duijf, Pascal H. G., Liu, Cheng, McTaggart, Matthew, Beard, Sam, O’Byrne, Kenneth J., Richard, Derek J.
Publicado 2021